---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-000902"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:25:11.935850+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Vistagen begins using updated corporate presentation on January 8, 2024

## Summary
- New corporate presentation adopted by Vistagen Therapeutics on Jan 8, 2024.
- Presentation attached as Exhibit 99.1; no financial or pipeline details provided in the filing.
- Item 7.01 disclosure; information is furnished, not filed, under SEC rules.

## SEC filing metadata
- accession: 0001437749-24-000902
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000143774924000902/0001437749-24-000902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000143774924000902/vtgn20240108_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-000902
- JSON: https://secwatch.observer/filing/0001437749-24-000902.json
- Plain text: https://secwatch.observer/filing/0001437749-24-000902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.